glp 1 and perimenopause GLP-1 Microdosing for Perimenopause: Benefits & Risks One Year on a GLP-1

Management primarily emphasizes lifestyle modifications, particularly weight reduction, as approximately 80% of PCOS patients are overweight or obese [5]

Intriguingly, a blockade of central estrogen receptors reduces the effect of a GLP-1R analog (exendin-4) on food-motivated behavior in both sexes, indicating that estrogen may modulate the effects of GLP-1 analogs not only in females but also in males (40)

GLP-1 medications can help manage blood sugar levels, reduce appetite, and support weight loss

Semaglutides ability to help maintain appetite suppression over the long term without significant side effects makes it an ideal option for individuals seeking lasting weight loss results

Timeline based on typical patient experience and clinical trial data

The remaining 33 trials (36%) reported no industry funding or were publicly funded